Healthcare -
Biotechnology - NASDAQ - US
$ 1.645
15.6 %
$ 20 M
Market Cap
-0.43
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
HOOKIPA Pharma Inc.
| Revenue | 43.9 M |
| Cost Of Revenue | 0 |
| Gross Profit | 43.9 M |
| Operating Expenses | 95.4 M |
| Operating Income | -51.5 M |
| Other Expenses | -7.95 M |
| Net Income | -43.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 43.9 | 20.1 | 14.2 | 18.4 | 19.6 | 11.9 | 7.6 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 3.6 | 3.6 | 4.6 | 53.1 | 46.3 | 22.0 | 0.4 |
| Gross Profit | 43.9 | 16.6 | 10.6 | 13.8 | (33.5) | (34.4) | (14.3) | (0.4) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 95.4 | 117.8 | 87.4 | 100.1 | 72.9 | 63.0 | 23.2 | 12.1 |
| Selling, General and Administrative Expenses | 20.2 | 18.6 | 18.8 | 17.3 | 18.1 | 16.7 | 6.8 | 4.4 |
| Research and Development Expenses | 68.5 | 86.4 | 68.6 | 82.9 | 54.8 | 46.3 | 22.0 | 9.8 |
| Operating Income | (51.5) | (97.7) | (73.2) | (81.7) | (53.3) | (51.1) | (21.2) | (14.2) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 2 K | 0.3 | 0.7 | 0.9 | 0.8 | 0.9 | 0.8 | 0.6 |
| Total Other Income | 7.8 | 16.5 | 8.5 | 6.0 | 9.2 | 8.0 | 5.0 | 1.4 |
| Pre-Tax Income | (43.6) | (81.2) | (64.9) | (75.7) | (44.1) | (43.0) | (16.2) | (12.7) |
| NET INCOME | ||||||||
| Tax Provision | (0.1) | 0.4 | 0.2 | 1 K | (10.3) | (8.9) | 24 K | 4 K |
| Net Income | (43.5) | (81.6) | (64.9) | (75.7) | (44.1) | (43.0) | (16.2) | (12.7) |
| EPS | 3.47 | 8.63 | 9.91 | 23 | 16.9 | 24.1 | 178 | 140 |